OvaSMART™ is the first portable medical device using our proprietary biosensor micro-chip technology that allows physicians and health-care providers the ability to quickly, and effectively detect the presence of ovarian cancer cells in a patient’s body. As the flagship product of Sensor-Kinesis’ (SKC) breakthrough biosensor platform for the early detection of disease within the human body, OvaSMART™ has been specifically engineered to detect one of the leading threats to woman’s health, ovarian cancer. It is anticipated that in the U.S. alone, more than 22,000 woman will be diagnosed in 2016 and that approximately 14,000 woman will succumb to this tragic disease. Although survival rates continue to increase, those diagnosed with ovarian cancer only hold a 46% chance of survival beyond five years.
One of the key factors to increasing the ability for physicians to effectively combat this disease is early detection. OvaSMART™ not only can provide accurate detection at an earlier stage and at a substantially lower cost, detection can now be done in the privacy of a physician’s office in a matter of minutes. Where time is the critical factor in the treatment of cancer, OvaSMART™ provides a major enhancement to the the arsenal of tools physicians and health-care providers have in ensuring the health of their patients.
OvaSMART™ represents the first in a series of biosensor-based devices that will be able to provide early detection of a variety of life-threatening illnesses. In addition SKC is in development of an in-home version of OvaSMART™ that will allow woman to be able to monitor the presence of ovarian cancer at its earliest stage.